概要
Conference: April 7-8, 2025
DIA’s Global Labeling Conference brings together medical product labeling professionals to address the challenges of developing and managing clear, accurate, and compliant labeling information for prescription drugs, biologics, and medical devices. As digital technology, patient needs, and regulatory landscapes evolve, this conference provides a platform for industry and regulatory experts to share knowledge, best practices, and tools for creating effective labeling that meets the needs of patients, providers, and payers worldwide.
While we develop our 2025 agenda, please take a moment to review the 2024 final agenda.
Participant Testimonials
It is hard to quantify the value of having access to this diversity and depth of experience. There were aspects of the regulatory business that I learned more about in 2 days than in ten years at my company. - Ken Zerfass - Eli Lilly
The presenters were excellent and discussions broadened my knowledge. - Thomas Kilker - Jazz Pharmaceuticals
This labeling event was very well organized and there was ample time for networking with global colleagues. - Daria Blanco - Daiichi Sankyo
プログラム委員会
-
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Deborah Bebbington Head Global Labeling
Bayer Plc, United Kingdom -
Hayley Parker, PhD, MSc Senior Vice President
Pepgen Inc., United States -
Halley A. Baker, RN Practice Leader, Regulatory Labeling
Opus Regulatory, United States -
Amy Mitchell Associate Director, CMC Regulatory
GlaxoSmithKline, United States -
Kelly Treonze, MS Head, Global Labeling Strategy
Merck & Co., Inc., United States -
Gina Monteiro Advisor
Eli Lilly and Company, United States -
Mary Beth Wilusz Head, Regulatory Labeling Operations and Compliance
Daiichi Sankyo, Inc., United States -
Sylvie Pujol Sr. Director, Head of Global Labeling, Global Regulator Affairs
Ipsen, France -
Gerrit Nijveldt, MS, MSc Global Labeling Consultant
Opus Regulatory Inc., United States -
Kathleen Salazar, MA, MBA Head, Global Labeling Implementation
Johnson & Johnson Innovative Medicine, United States
